PriceTargets.com logo

NYSE:UPH - UpHealth Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $8.38
  • Forecasted Upside: 1,063.19 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$0.72 As of 05/25/2022 05:00 PM ET
▼ -0.02 (-2.70%)

This chart shows the closing price for UPH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UpHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPH

Analyst Price Target is $8.38
▲ +1,063.19% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for UpHealth in the last 3 months. The average price target is $8.38, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 1,063.19% upside from the last price of $0.72.

This chart shows the closing price for UPH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in UpHealth.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/25/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/13/2022BenchmarkLower Price Target$5.00 ➝ $4.00High
3/31/2022Northland SecuritiesLower Price TargetOutperform$10.50 ➝ $4.50High
3/31/2022Lake Street CapitalDowngradeBuy ➝ HoldHigh
11/2/2021BenchmarkLower Price TargetBuy$14.00 ➝ $9.00Low
10/25/2021Lake Street CapitalInitiated CoverageBuyLow
8/10/2021Colliers SecuritiesReiterated RatingBuyHigh
7/22/2021OppenheimerInitiated CoverageOutperform$12.00High
7/13/2021Colliers SecuritiesReiterated RatingBuy$13.00High
7/13/2021Northland SecuritiesInitiated CoverageOutperform$13.00High
6/8/2021Colliers SecuritiesReiterated RatingBuyHigh
(Data available from 5/25/2017 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2021
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2021
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2022
  • 5 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
4/25/2022
  • 5 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2022

Current Sentiment

  • 5 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

UpHealth logo
UpHealth, Inc. operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; MedQuest Pharmacy, a full-service retail and compounding pharmacy licensed that dispenses prescribed medications shipped directly to patients; and Telehealth solutions. The company is based in Delray Beach, Florida.
Read More

Today's Range

Now: $0.72
Low: $0.70
High: $0.74

50 Day Range

MA: $1.16
Low: $0.64
High: $2.33

52 Week Range

Now: $0.72
Low: $0.62
High: $10.72

Volume

359,631 shs

Average Volume

763,884 shs

Market Capitalization

$102.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.03

Frequently Asked Questions

What sell-side analysts currently cover shares of UpHealth?

The following Wall Street sell-side analysts have issued reports on UpHealth in the last twelve months: Benchmark Co., Colliers Securities, Lake Street Capital, Northland Securities, Oppenheimer Holdings Inc., and Zacks Investment Research.
View the latest analyst ratings for UPH.

What is the current price target for UpHealth?

0 Wall Street analysts have set twelve-month price targets for UpHealth in the last year. Their average twelve-month price target is $8.38, suggesting a possible upside of 1,063.2%.
View the latest price targets for UPH.

What is the current consensus analyst rating for UpHealth?

UpHealth currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UPH will outperform the market and that investors should add to their positions of UpHealth.
View the latest ratings for UPH.

How do I contact UpHealth's investor relations team?

UpHealth's physical mailing address is 1731 Embarcadero Road Suite 200, PALO ALTO CA, 94303. The company's listed phone number is 312-618-1322 and its investor relations email address is [email protected] The official website for UpHealth is www.gigcapital2.com. Learn More about contacing UpHealth investor relations.